Study Design: Blinded, placebo-controlled, prospective clinical trial.

Purpose: To examine the effects of botulinum toxin type A (BTX-A) injections into plantar flexor muscles in stroke patients with equinovarus gait.

Subjects: 15 post-stroke and 10 matched neurologically intact subjects.

Methods: Modified Ashworth Scale (MAS) and Fugl-Meyer assessment of physical function scale scores along with surface EMG collected before and up to 12 weeks after BTX-A injections to plantar flexor muscle motor points in stroke subjects. Saline placebo injections were performed in a subset of stroke subject group.

Results: MAS scores were decreased at 4, 8 and 12 weeks but F-M scores did not improve until 12 weeks post injection. Multi-muscle EMG patterns showed the return of volitional dorsiflexor activity in 11 and a decrease of antagonistic and distant coactivation in all but one of the 15.

Conclusions: BTX-A is effective in reducing antagonistic and distant muscle activation that impedes volitional dorsiflexion.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2012.03.014DOI Listing

Publication Analysis

Top Keywords

botulinum toxin
8
toxin type
8
btx-a injections
8
injections plantar
8
plantar flexor
8
antagonistic distant
8
modification altered
4
altered ankle
4
ankle motor
4
motor control
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!